Distrust in healthcare has been America’s hard pill to swallow especially for the BIPOC community. But how can members of healthcare, like physicians, regain the trust of their BIPOC patients?

Will telemedicine remain as a mainstay for myeloma patients after the pandemic? Learn the prime points from the Myeloma TelemEDucation Empowerment Resource Center.

When faced with the diagnosis of breast cancer for the first time, it can be overwhelming. Dr. Regina Hampton explains key players in the breast cancer treatment game.

New research from Heinz Ludwig, MD et al explores the global interrelations between Multiple Myeloma (MM) mortality and countries’ economic resources, patient empowerment, and health access and quality. The study is intended to inform about the associations between these factors, and to improve diagnosis, management, and outcome of patients globally.

The Prostate Cancer TelemEDucation Resource Center helps improve prostate cancer patients’ and care partners’ familiarity with healthcare, and thus increase quality of care regardless of the COVID pandemic, geographical location, or racial disparities. The program focuses on the specific needs of Black men and other vulnerable communities to most effectively reduce healthcare disparities.

Black American women have less breast cancer but die at higher rates than our white counterparts. Why is there a disparity?

Studies centering on vaccinations for myeloma patients have been limited in the past due to their low participation rate in trials coupled with negligent measures of patient outcomes. Learn about compilation of vaccination data.

Access to low-cost nutritious food stores is limited in BIPOC communities, but efforts are underway to dismantle the inaccessibility.

Months into the coronavirus pandemic in the U.S., what have we learned about the effects of the virus on Black, Indigenous, and People of Color (BIPOC) populations?

Blood transfusions, organ transplants, and bone marrow transplants can be detrimental situations for any person who needs one. But what special considerations are there for those who are of BIPOC and mixed races?

Blood transfusions, organ transplants, and bone marrow transplants can be detrimental situations for any person who needs one. But what special considerations are there for those who are of BIPOC and mixed races?

Dr. Andrew Campbell shares the reasons that drive him to help people with sickle cell disease in this Heart Behind the White Coat (HBWC) program.

Dr. Andrew Campbell shares his key points for medical students to consider and describes the traits it takes to be a provider of sickle cell care in this Heart Behind the White Coat (HBWC) program.

Myeloma experts Dr. Sikander Ailawadhi and Dr. Saad Usmani share disparities in age of diagnosis for MGUS and active myeloma in BIPOC patients.

For breast cancer patients, the balance of one’s mental state can be a determining factor in the outcome of one’s physical state. For the BIPOC community, gaining control of one’s mental state may pose more of a challenge.

The Patient Empowerment Network Diverse Partners in Your Myeloma Care program focuses on helping to improve health outcomes for underserved myeloma patients. We’ll take a look at what we know, what we’ve learned, and what help and resources are needed to continue advancing care for BIPOC myeloma patients.

Dr. Alexander Glaros shares why sickle cell disease education and research are so important to achieve health equity for underserved patients in this Heart Behind the White Coat (HBWC) program.

Sickle cell disease expert Dr. Alexander Glaros shares why passion is important for disease experts and the differences in health equities for adult and pediatric patients.

We’ve had the opportunity to speak with Dr. Andrew Campbell, director of the Consortium for the Advancement of Sickle Cell Research (CASiRe), to discuss the recent publication of two important research papers, and to go into greater depth about the systemic barriers that prevent access to care for sickle cell patients across the globe.

Racial and ethnic minority groups (REMGs) will make up the majority of the population in the near future. This is problematic because present inequities render REMGs disproportionately vulnerable and sick.